Your browser doesn't support javascript.
loading
Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
Tsuzuki, Shinya; Hayakawa, Kayoko; Uemura, Yukari; Shinozaki, Tomohiro; Matsunaga, Nobuaki; Terada, Mari; Suzuki, Setsuko; Asai, Yusuke; Kitajima, Koji; Saito, Sho; Yamada, Gen; Shibata, Taro; Kondo, Masashi; Izumi, Kazuo; Hojo, Masayuki; Mizoue, Tetsuya; Yokota, Kazuhisa; Nakamura-Uchiyama, Fukumi; Saito, Fumitake; Sugiura, Wataru; Ohmagari, Norio.
Afiliação
  • Tsuzuki S; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: stsuzuki@hosp.ncgm.go.jp.
  • Hayakawa K; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: khayakawa@hosp.ncgm.go.jp.
  • Uemura Y; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: yuemura@hosp.ncgm.go.jp.
  • Shinozaki T; Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan. Electronic address: shinozaki@rs.tus.ac.jp.
  • Matsunaga N; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: nomatsunaga@hosp.ncgm.go.jp.
  • Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: materada@hosp.ncgm.go.jp.
  • Suzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: sesuzuki@hosp.ncgm.go.jp.
  • Asai Y; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: yuasai@ri.ncgm.go.jp.
  • Kitajima K; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: kkitajima@hosp.ncgm.go.jp.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssaito@hosp.ncgm.go.jp.
  • Yamada G; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: gyamada@hosp.ncgm.go.jp.
  • Shibata T; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan. Electronic address: tarshiba@ncc.go.jp.
  • Kondo M; Center for Clinical Trial and Research Support, Fujita Health University, Aichi, Japan. Electronic address: mkond@fujita-hu.ac.jp.
  • Izumi K; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: kaizumi@hosp.ncgm.go.jp.
  • Hojo M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mhojo@hosp.ncgm.go.jp.
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mizoue@hosp.ncgm.go.jp.
  • Yokota K; Department of Infectious Diseases, Tokyo Metropolitan Health and Medical Corporation Ebara Hospital, Tokyo, Japan. Electronic address: kazuhisa_yokota@tokyo-hmt.jp.
  • Nakamura-Uchiyama F; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan. Electronic address: fukumi_nakamura@tmhp.jp.
  • Saito F; Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan. Electronic address: fumitake.saito@eijuhp.com.
  • Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: wsugiura@hosp.ncgm.go.jp.
  • Ohmagari N; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: nohmagari@hosp.ncgm.go.jp.
Int J Infect Dis ; 118: 119-125, 2022 May.
Article em En | MEDLINE | ID: mdl-35192953
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article